Gaseous signalling molecule SO2 via Hippo‑MST pathway to improve myocardial fibrosis of diabetic rats

Liu,Maojun; Liu,Shengquan; Tan,Wenting; Tang,Fen; Long,Junrong; Li,Zining; Liang,Biao; Chu,Chun; Yang,Jun

doi:10.3892/mmr.2017.7714

Gaseous signalling molecule SO2 via Hippo‑MST pathway to improve myocardial fibrosis of diabetic rats

Authors:
- Maojun Liu
- Shengquan Liu
- Wenting Tan
- Fen Tang
- Junrong Long
- Zining Li
- Biao Liang
- Chun Chu
- Jun Yang
View Affiliations

Affiliations: Department of Cardiology, The First Affiliated Hospital of University of South China, Hengyang, Hunan 421001, P.R. China, Department of Pharmacy, The Second Affiliated Hospital of University of South China, Hengyang, Hunan 421001, P.R. China
Published online on: October 4, 2017 https://doi.org/10.3892/mmr.2017.7714
Pages: 8953-8963
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recent studies have indicated the existence of an endogenous sulfur dioxide (SO2)‑generating system in the cardiovascular system. The present study aimed to discuss the function and regulatory mechanism of gaseous signal molecule SO2 in inhibiting apoptosis and endoplasmic reticulum stress (ERS) via the Hippo‑MST signaling pathway to improve myocardial fibrosis of diabetic rats. A total of 40 male Sprague‑Dawley rats were randomly divided into four groups (10 rats per group): Normal control group (control group), diabetic rats group [streptozotocin (STZ) group], SO2 intervention group (STZ+SO2 group) and diabetes mellitus rats treated with L‑Aspartic acid β‑hydroxamate (HDX) group (HDX group). Diabetic rats models were established by intra‑peritoneal injection of STZ (40 mg/kg) Following model establishment, intra‑peritoneal injection of Na2SO3/NaHSO3 solution (0.54 mmol/kg) was administered in the STZ+SO2 group, and HDX solution (25 mg/kg/week) was administered in the HDX group. A total of 4 weeks later, echocardiography was performed to evaluate rats' cardiac function; Masson staining, terminal deoxynucleotidyl transferase dUTP nick end labeling staining and transmission electron microscopy examinations were performed to observe myocardial morphological changes. ELISA was employed to determine the SO2 content. Western blot analysis was performed to detect the expression of proteins associated with apoptosis, ERS and the Hippo‑MST signalling pathway. Compared with the control group, the STZ group and HDX group had a disordered arrangement of myocardial cells with apparent myocardial fibrosis, and echocardiography indicated that the cardiac function was lowered, there was an obvious increase of apoptosis in myocardial tissue, the expression levels of apoptosis‑associated protein B‑cell lymphoma associated protein X, caspase‑3 and caspase‑9 were upregulated, and Bcl‑2 expression was downregulated. The expression of ERS and Hippo‑MST pathway‑associated proteins, including CHOP, GRP94, MST1 and MST2, were significantly upregulated. By contrast, these above‑mentioned changes were reversed by SO2 treatment. Compared with STZ group, the HDX group had a further increase of myocardial fibrosis and apoptosis, while there were no statistically significant differences in the expression of Bax/Bcl‑2, caspase‑3, caspase‑9 and ERS and Hippo‑MST pathway‑associated proteins. The results of the present study demonstrated that the gaseous signal molecule SO2 can effectively improve the myocardial fibrosis of diabetic rats, and its mechanism may be associated with reduced apoptosis and ERS by downregulated Hippo‑MST pathway.

View Figures

View References

1	Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al: Prevalence of diabetes among men and women in China. N Engl J Med. 362:1090–1101. 2010. View Article : Google Scholar : PubMed/NCBI
2	Jia G, DeMarco VG and Sowers JR: Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 12:144–153. 2016. View Article : Google Scholar : PubMed/NCBI
3	Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K and Matsuo H: Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation. 101:899–907. 2000. View Article : Google Scholar : PubMed/NCBI
4	Varga ZV, Giricz Z, Liaudet L, Haskó G, Ferdinandy P and Pacher P: Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta. 1852:232–242. 2015. View Article : Google Scholar : PubMed/NCBI
5	Zhang JS, Hou YL, Lu WW, Ni XQ, Lin F, Yu YR, Tang CS and Qi YF: Intermedin1-53 protects against myocardial fibrosis by inhibiting endoplasmic reticulum stress and inflammation induced by homocysteine in apolipoprotein E-deficient mice. J AtherosclerThromb. 23:1294–1306. 2016.
6	Li F, Luo J, Wu Z, Xiao T, Zeng O, Li L, Li Y and Yang J: Hydrogen sulfide exhibits cardioprotective effects by decreasing endoplasmic reticulum stressin a diabetic cardiomyopathy rat model. Mol Med Rep. 14:865–873. 2016. View Article : Google Scholar : PubMed/NCBI
7	Bugger H and Abel ED: Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 57:660–671. 2014. View Article : Google Scholar : PubMed/NCBI
8	Nerheim P, Krishnan SC and Olshansky B: Apoptosis in the genesis of cardiac rhythm disorders. Cardiology clinics. 19:155–163. 2001. View Article : Google Scholar : PubMed/NCBI
9	Huang Y, Tang C, Du J and Jin H: Endogenous sulfur dioxide: A new member of gasotransmitter family in the cardiovascular system. Oxid Med Cell Longev. 2016:89619512016. View Article : Google Scholar : PubMed/NCBI
10	Pan D: The hippo signaling pathway in development and cancer. Dev Cell. 19:491–505. 2010. View Article : Google Scholar : PubMed/NCBI
11	Radu M and Chernoff J: The DeMSTification of mammalian Ste20 kinases. Curr Bio. 19:R421–R425. 2009. View Article : Google Scholar
12	Lin J, Zhang L, Zhang M, Hu J, Wang T, Duan Y, Man W, Wu B, Feng J, Sun L, et al: Mst1 inhibits CMECs autophagy and participates in the development of diabetic coronary microvascular dysfunction. Sci Rep. 6:341992016. View Article : Google Scholar : PubMed/NCBI
13	Chen Y, Du J, Zhao YT, Zhang L, Lv G, Zhuang S, Qin G and Zhao TC: Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc Diabetol. 14:992015. View Article : Google Scholar : PubMed/NCBI
14	Zhang L, Ding WY, Wang ZH, Tang MX, Wang F, Li Y, Zhong M, Zhang Y and Zhang W: Erratum to: Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy. J Transl Med. 14:3092016. View Article : Google Scholar : PubMed/NCBI
15	Zhang B, Shen Q, Chen Y, Pan R, Kuang S, Liu G, Sun G and Sun X: Myricitrin alleviates oxidative stress-induced inflammation and apoptosis and protects mice against diabetic cardiomyopathy. Sci Rep. 7:442392017. View Article : Google Scholar : PubMed/NCBI
16	Yu W, Zha W, Guo S, Cheng H, Wu J and Liu C: Flos puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice. PLoS One. 9:e980442014. View Article : Google Scholar : PubMed/NCBI
17	Zhou W, Yang J, Zhang DI, Li F, Li G, Gu Y and Luo M: Role of Bcl-2/adenovirus E1B 19 kDa-interacting protein 3 in myocardial cells in diabetes. Exp Ther Med. 10:67–73. 2015. View Article : Google Scholar : PubMed/NCBI
18	Biden TJ, Boslem E, Chu KY and Sue N: Lipotoxic endoplasmic reticulum stress, β cell failure and type 2 diabetes mellitus. Trends Endocrinol Metab. 25:389–398. 2014. View Article : Google Scholar : PubMed/NCBI
19	Tang C, Koulajian K, Schuiki I, Zhang L, Desai T, Ivovic A, Wang P, Robson-Doucette C, Wheeler MB, Minassian B, et al: Glucose-induced beta cell dysfunction in vivo in rats: Link between oxidative stress and endoplasmic reticulum stress. Diabetologia. 55:1366–1379. 2012. View Article : Google Scholar : PubMed/NCBI
20	Avruch J, Zhou D, Fitamant J, Bardeesy N, Mou F and Barrufet LR: Protein kinases of the Hippo pathway: Regulation and substrates. Semin Cell Dev Biol. 23:770–784. 2012. View Article : Google Scholar : PubMed/NCBI
21	Meng Z, Moroishi T and Guan KL: Mechanisms of Hippo pathway regulation. Genes Dev. 30:1–17. 2016. View Article : Google Scholar : PubMed/NCBI
22	Praskova M, Xia F and Avruch J: MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol. 18:311–321. 2008. View Article : Google Scholar : PubMed/NCBI
23	Nakamura M, Zhai P, Del Re DP, Maejima Y and Sadoshima J: Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury. JCI Insight. 1:e862172016. View Article : Google Scholar : PubMed/NCBI
24	Lee GJ, Yan L, Vatner DE and Vatner SF: Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis ratherthan myocyte apoptosis. Basic Res Cardiol. 110:72015. View Article : Google Scholar : PubMed/NCBI
25	Hu J, Man W, Shen M, Zhang M, Lin J, Wang T, Duan Y, Li C, Zhang R, Gao E, et al: Luteolin alleviates post-infarction cardiac dysfunction by up-regulating autophagy through Mst1 inhibition. J Cell Mol Med. 20:147–156. 2016. View Article : Google Scholar : PubMed/NCBI
26	Yamamoto S, Yang G, Zablocki D, Liu J, Hong C, Kim SJ, Soler S, Odashima M, Thaisz J, Yehia G, et al: Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest. 111:1463–1474. 2003. View Article : Google Scholar : PubMed/NCBI
27	Zhang M, Zhang L, Hu J, Lin J, Wang T, Duan Y, Man W, Feng J, Sun L, Jia H, et al: MST1 coordinately regulates autophagy and apoptosis in in mice. Diabetologia. 59:2435–2447. 2016. View Article : Google Scholar : PubMed/NCBI
28	Ardestani A and Maedler K: MST1: A promising therapeutic target to restore functional beta cell mass in diabetes. Diabetologia. 59:1843–1849. 2016. View Article : Google Scholar : PubMed/NCBI
29	Shen Y, Shen Z, Luo S, Guo W and Zhu YZ: The cardioprotective effects of hydrogen sulfide in heart diseases: From molecular mechanisms to therapeutic potential. Oxid Med Cell Longev. 2015:9251672015. View Article : Google Scholar : PubMed/NCBI
30	Stipanuk MH: Sulfur amino acid metabolism: Pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr. 24:539–577. 2004. View Article : Google Scholar : PubMed/NCBI
31	Singer TP and Kearney EB: Intermediary metabolism of L-cysteinesulfinic acid in animal tissues. Arch Biochem Biophys. 61:397–409. 1956. View Article : Google Scholar : PubMed/NCBI
32	Jin H, Liu AD, Holmberg L, Zhao M, Chen S, Yang J, Sun Y, Chen S, Tang C and Du J: The role of sulfur dioxide in the regulation of mitochondrion-related cardiomyocyte apoptosis in ratswith isopropylarterenol-induced myocardial injury. Int J Mol Sci. 14:10465–10482. 2013. View Article : Google Scholar : PubMed/NCBI
33	Huang Y, Shen Z, Chen Q, Huang P, Zhang H, Du S, Geng B, Zhang C, Li K, Tang C, et al: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway invascular smooth muscle cells. Sci Rep. 6:195032016. View Article : Google Scholar : PubMed/NCBI
34	Zhang H, Huang Y, Bu D, Chen S, Tang C, Wang G, Du J and Jin H: Endogenous sulfur dioxide isa novel adipocyte-derived inflammatory inhibitor. Sci Rep. 6:270262016. View Article : Google Scholar : PubMed/NCBI
35	Liu D, Huang Y, Bu D, Liu AD, Holmberg L, Jia Y, Tang C, Du J and Jin H: Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinasepathway mediated by cAMP/PKA signaling. Cell Death Dis. 5:e12512014. View Article : Google Scholar : PubMed/NCBI
36	Wang XB, Jin HF, Tang CS and Du JB: The biological effect of endogenous sulfur dioxide in the cardiovascular system. Eur J Pharmacol. 670:1–6. 2011. View Article : Google Scholar : PubMed/NCBI
37	Huang P, Sun Y, Yang J, Chen S, Liu AD, Holmberg L, Huang X, Tang C, Du J and Jin H: The ERK1/2 signaling pathway is involved in sulfur dioxide preconditioning-induced protection against cardiac dysfunction in isolated perfused rat heart subjected tomyocardial ischemia/reperfusion. Int J Mol Sci. 14:22190–22201. 2013. View Article : Google Scholar : PubMed/NCBI
38	Yu W, Liu D, Liang C, Ochs T, Chen S, Chen S, Du S, Tang C, Huang Y, Du J and Jin H: Sulfur dioxide protects against collagen accumulation in pulmonary artery in association with downregulation of the transforming growth factor β1/smad pathway in pulmonary hypertensive rats. J Am Heart Assoc. 5:e0039102016. View Article : Google Scholar : PubMed/NCBI
39	Chen Q, Zhang L, Chen S, Huang Y, Li K, Yu X, Wu H, Tian X, Zhang C, Tang C, et al: Downregulated endogenous sulfur dioxide/aspartate aminotransferase pathway is involved inangiotensin II-stimulated cardiomyocyte autophagy and myocardial hypertrophy in mice. Int J Cardiol. 225:392–401. 2016. View Article : Google Scholar : PubMed/NCBI
40	Liu J, Huang Y, Chen S, Tang C, Jin H and Du J: Role of endogenous sulfur dioxide in regulating vascular structural remodeling in hypertension. Oxid Med Cell Longev. 2016:45290602016. View Article : Google Scholar : PubMed/NCBI